Epilepsy Talk

Dilantin – Hero or Horror?

May 1, 2022
27 Comments

Since it first came out, Dilantin has always had its fans and its detractors.

Who can forget Jack Nicholson’s out-of-control behavior as the “crazy” in Ken Kesey’s “One Flew Over the Cuckoo’s Nest”!


Stop the FDA from regulating supplements and nutrients

December 3, 2021
8 Comments

The Dietary Supplement Labeling Act pretends to be consumer-oriented, but instead will give the FDA redundant power that it could easily misuse, restricting your access to nutritional supplements and raising the cost of buying them.

In short, nutritional supplements will be regulated like prescription drugs…


$56,000 a year for an unproven drug!

October 30, 2021
Leave a Comment

Getting the FDA to retract a decision, is like getting the toothpaste back in the tube, after it’s been squeezed out…

Whether it’s “yes” or “no,” there is no “maybe so”.

A good example is the new all star Alzheimer’s drug aducanumab.

Whether it’s “yes” or “no,” there is no “maybe so”.


What’s Really In Your Meds?

October 29, 2021
5 Comments

“As Americans become more concerned about quality issues with prescription medications made abroad, one company is trying to offer an additional layer of reassurance — by doing chemical analysis before dispensing drugs to patients.


What Is the FDA Thinking?

October 2, 2021
3 Comments

Getting the FDA to retract a decision is like getting the toothpaste back into the tube, once it’s been squeezed out.

Take the current all-star Alzheimer’s drug aducanumab. It’s not a proven but it IS approved. To the hefty price tag of $56,000 a year!


$112 billion new Alzheimer’s drug in question

July 13, 2021
4 Comments

Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…

Whether it’s “yes” or “no,” there is no “maybe so”.

A good example is the new all star Alzheimer’s drug aducanumab.


The first new Alzheimer’s drug in 18 years may not work.

June 17, 2021
Leave a Comment

Getting the FDA to retract a decision is like getting the toothpaste back in the tub, after it’s been squeezed out…

Whether it’s “yes” or “no,” there is no “maybe so”.

A good example is the new all-star Alzheimer’s drug aducanumab.


Medical Marijuana — It’s Here to Stay…

March 27, 2021
14 Comments

Let’s face it. The time has come.

Even the FDA has opened its eyes with new clinical trials.

Although the AMA chooses to keep their heads in the sand. For now.

It used to be popular to debate the merits and dangers of medical marijuana.

For example, it could lead to addiction. Like cocaine. (Oh please!)

But now, there’s clinically proven scientific proof, with more to come…


Anti-Epilepsy Drugs and Osteoporosis – It’s Not Just a Women’s Disease

February 24, 2021
17 Comments

A research team consisting of epilepsy specialists and epidemiologists (persons who study the causes and control of diseases) reports on a study that answered an important but simple question:

Do anti-seizure drugs cause reductions in bone density?

Why ask this question?


Can I Substitute Generic Drugs for My Anti-Seizure Medications?

July 24, 2020
35 Comments

The controversy about generic drugs continues…


Next Page »

    About the author

    Phylis Feiner Johnson

    Phylis Feiner Johnson

    I've been a professional copywriter for over 35 years. I also had epilepsy for decades. My mission is advocacy; to increase education, awareness and funding for epilepsy research. Together, we can make a huge difference. If not changing the world, at least helping each other, with wisdom, compassion and sharing.

    View Full Profile →

    Enter your email address to follow this blog and receive free notifications of new posts by email.

    Join 3,193 other followers

    Follow Epilepsy Talk on WordPress.com